Adenovirus 5 Vector Genetically Re-Targeted by an Affibody Molecule With Specificity for Tumor Antigen HER2/neu

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7701027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

An Ad5[E1-, E2b-]-Her2/Neu Vector Induces Immune Responses and Inhibits HER2/neu Expressing Tumor Progression in Ad5 Immune Mice

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2011English

Persistent, Antigen-Specific, Therapeutic Antitumor Immunity by Dendritic Cells Genetically Modified With an Adenoviral Vector to Express a Model Tumor Antigen

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

HER2/neu: An Increasingly Important Therapeutic Target. Part 2: Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology

Clinical Investigation
2014English

506. Adenovirus Vectors Transductionally Retargeted to Her2/Neu for Prostate Tumour Treatment

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Genetically Engineered T Cells Expressing a HER2-specific Chimeric Receptor Mediate Antigen-Specific Tumor Regression

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2008English

In Vivo Targeting of HER2-positive Tumor Using 2-Helix Affibody Molecules

Amino Acids
Organic ChemistryBiochemistryClinical Biochemistry
2011English

Transcriptional Repression of the Neu Protooncogene by the Adenovirus 5 E1A Gene Products.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy